Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

ClinicalTrials.gov ID: NCT01442194

Public ClinicalTrials.gov record NCT01442194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 5:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term, Prospective,Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further explore the incidence of selected safety- related outcomes and to further monitor the overall safety profile of fingolimod under conditions of routine medical practice.

Study identification

NCT ID
NCT01442194
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
3,076 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2011
Primary completion
Jul 9, 2020
Completion
Jul 9, 2020
Last update posted
Jan 13, 2022

2011 – 2020

United States locations

U.S. sites
208
U.S. states
42
U.S. cities
184
Facility City State ZIP Site status
Novartis Investigative Site Birmingham Alabama 35209
Novartis Investigative Site Birmingham Alabama 35233-0271
Novartis Investigative Site Birmingham Alabama 35235
Novartis Investigative Site Cullman Alabama 35058
Novartis Investigative Site Mobile Alabama 36617
Novartis Investigative Site Phoenix Arizona 85013
Novartis Investigative Site Sottsdale Arizona 85258
Novartis Investigative Site Tucson Arizona 85718
Novartis Investigative Site Bakersfield California 93311
Novartis Investigative Site Banning California 92220
Novartis Investigative Site Burbank California 91505
Novartis Investigative Site Fresno California 93710
Novartis Investigative Site Fullerton California 92835
Novartis Investigative Site Huntington Beach California 92649
Novartis Investigative Site Irvine California 92618
Novartis Investigative Site Loma Linda California 92354
Novartis Investigative Site Los Angeles California 90073
Novartis Investigative Site Newport Beach California 92660
Novartis Investigative Site Oceanside California 92056
Novartis Investigative Site Placentia California 92870
Novartis Investigative Site Pomona California 91767
Novartis Investigative Site Redding California 96001
Novartis Investigative Site Santa Monica California 90404
Novartis Investigative Site Temecula California 92591
Novartis Investigative Site Aurora Colorado 80045
Novartis Investigative Site Basalt Colorado 81621
Novartis Investigative Site Colorado Springs Colorado 80907
Novartis Investigative Site Denver Colorado 80210
Novartis Investigative Site Fort Collins Colorado 80524
Novartis Investigative Site Louisville Colorado 80027
Novartis Investigative Site Parker Colorado 80138
Novartis Investigative Site Fairfield Connecticut 06824
Novartis Investigative Site Hartford Connecticut 6112
Novartis Investigative Site Waterbury Connecticut 06708
Novartis Investigative Site Dover Delaware 19901
Novartis Investigative Site Newark Delaware 19713
Novartis Investigative Site Washington D.C. District of Columbia 20007
Novartis Investigative Site Washington D.C. District of Columbia 20037
Novartis Investigative Site Bradenton Florida 34205
Novartis Investigative Site Clermont Florida 34711
Novartis Investigative Site Delray Beach Florida 33445
Novartis Investigative Site Doral Florida 33136
Novartis Investigative Site Hollywood Florida 33021
Novartis Investigative Site Jupiter Florida 33458
Novartis Investigative Site Maitland Florida 32751
Novartis Investigative Site Miami Florida 33032
Novartis Investigative Site Miami Florida 33144
Novartis Investigative Site Miami Florida 33155
Novartis Investigative Site Naples Florida 34102
Novartis Investigative Site Orlando Florida 32806
Novartis Investigative Site Ormond Beach Florida 32174
Novartis Investigative Site Panama City Florida 32405
Novartis Investigative Site Port Charlotte Florida 33952
Novartis Investigative Site Sarasota Florida 34233
Novartis Investigative Site Wellington Florida 33414
Novartis Investigative Site West Palm Beach Florida 33407
Novartis Investigative Site Weston Florida 33331
Novartis Investigative Site Atlanta Georgia 30309
Novartis Investigative Site Atlanta Georgia 30327
Novartis Investigative Site Augusta Georgia 30912
Novartis Investigative Site Macon Georgia 31210
Novartis Investigative Site Suwanee Georgia 30024
Novartis Investigative Site Arlington Heights Illinois 60004
Novartis Investigative Site Carbondale Illinois 62901
Novartis Investigative Site Flossmoor Illinois 60422
Novartis Investigative Site Marywood Illinois 60153
Novartis Investigative Site Peoria Illinois 61637
Novartis Investigative Site Anderson Indiana 46011
Novartis Investigative Site Indianapolis Indiana 46227
Novartis Investigative Site Indianapolis Indiana 46256
Novartis Investigative Site Lafayette Indiana 47905
Novartis Investigative Site Merrillville Indiana 46410
Novartis Investigative Site Des Moines Iowa 50314-2611
Novartis Investigative Site Kansas City Kansas 66160
Novartis Investigative Site Lenexa Kansas 66212
Novartis Investigative Site Overland Park Kansas 66210
Novartis Investigative Site Topeka Kansas 66606
Novartis Investigative Site Lexington Kentucky 40503
Novartis Investigative Site Lexington Kentucky 40513
Novartis Investigative Site Louisville Kentucky 40202
Novartis Investigative Site Hammond Louisiana 70403
Novartis Investigative Site Auburn Maine 04210
Novartis Investigative Site Bangor Maine 04401
Novartis Investigative Site Baltimore Maryland 21201
Novartis Investigative Site Baltimore Maryland 21209
Novartis Investigative Site Baltimore Maryland 21212
Novartis Investigative Site Bethesda Maryland 20814
Novartis Investigative Site Charlotte Hall Maryland 20622
Novartis Investigative Site Hagerstown Maryland 21741
Novartis Investigative Site Lutherville Maryland 21093
Novartis Investigative Site Waldorf Maryland 20603
Novartis Investigative Site Boston Massachusetts 02135
Novartis Investigative Site Boston Massachusetts 02215
Novartis Investigative Site Foxborough Massachusetts 02035
Novartis Investigative Site Springfield Massachusetts 01104
Novartis Investigative Site Wellesley Massachusetts 02481
Novartis Investigative Site Worcester Massachusetts 01608
Novartis Investigative Site Caro Michigan 48723
Novartis Investigative Site Detroit Michigan 48201
Novartis Investigative Site Jackson Michigan 49201
Novartis Investigative Site Owosso Michigan 48867
Novartis Investigative Site Rochester Hills Michigan 48301
Novartis Investigative Site Southfield Michigan 48034
Novartis Investigative Site Traverse City Michigan 49684-2340
Novartis Investigative Site Edina Minnesota 55435
Novartis Investigative Site Golden Valley Minnesota 55422
Novartis Investigative Site City of Saint Peters Missouri 63303
Novartis Investigative Site Springfield Missouri 65807
Novartis Investigative Site St Louis Missouri 63104
Novartis Investigative Site St Louis Missouri 63128
Novartis Investigative Site Great Falls Montana 59405
Novartis Investigative Site Hastings Nebraska 68901
Novartis Investigative Site Omaha Nebraska 68198-2045
Novartis Investigative Site Las Vegas Nevada 89106
Novartis Investigative Site Lebanon New Hampshire 03756
Novartis Investigative Site Fair Lawn New Jersey 07410
Novartis Investigative Site Livingston New Jersey 07039
Novartis Investigative Site Somerset New Jersey 08873
Novartis Investigative Site West Long Branch New Jersey 07764
Novartis Investigative Site Albany New York 12208
Novartis Investigative Site Amherst New York 14226
Novartis Investigative Site Brooklyn New York 11220
Novartis Investigative Site Cedarhurst New York 11516
Novartis Investigative Site Johnson City New York 13790
Novartis Investigative Site Kingston New York 12401
Novartis Investigative Site Lake Success New York 11042
Novartis Investigative Site New York New York 10003
Novartis Investigative Site Patchogue New York 11772
Novartis Investigative Site Plainview New York 11803
Novartis Investigative Site Poughkeepsie New York 12601
Novartis Investigative Site Staten Island New York 10306
Novartis Investigative Site Syracuse New York 13210
Novartis Investigative Site The Bronx New York 10467
Novartis Investigative Site Asheville North Carolina 28805
Novartis Investigative Site Asheville North Carolina 28806
Novartis Investigative Site Chapel Hill North Carolina 27599-9500
Novartis Investigative Site Charlotte North Carolina 28202
Novartis Investigative Site Charlotte North Carolina 28204
Novartis Investigative Site Durham North Carolina 27710
Novartis Investigative Site Hickory North Carolina 28602
Novartis Investigative Site Raleigh North Carolina 27607
Novartis Investigative Site Sanford North Carolina 27330
Novartis Investigative Site Wilmington North Carolina 28401
Novartis Investigative Site Bismarck North Dakota 58501
Novartis Investigative Site Bellevue Ohio 44811
Novartis Investigative Site Centerville Ohio 45459
Novartis Investigative Site Cincinnati Ohio 45219
Novartis Investigative Site Columbus Ohio 43210
Novartis Investigative Site Columbus Ohio 43221
Novartis Investigative Site Dayton Ohio 45408
Novartis Investigative Site Toledo Ohio 43614
Novartis Investigative Site Toledo Ohio 43623
Novartis Investigative Site Oklahoma City Oklahoma 73102
Novartis Investigative Site Oklahoma City Oklahoma 73104
Novartis Investigative Site Portland Oregon 97225
Novartis Investigative Site Springfield Oregon 97477
Novartis Investigative Site Greensburg Pennsylvania 15601
Novartis Investigative Site Meadowbrook Pennsylvania 19046
Novartis Investigative Site Philadelphia Pennsylvania 19107-5098
Novartis Investigative Site Philadelphia Pennsylvania 19107
Novartis Investigative Site Pittsburgh Pennsylvania 15243
Novartis Investigative Site Willow Grove Pennsylvania 19090
Novartis Investigative Site Beaufort South Carolina 29902
Novartis Investigative Site Camden South Carolina 29020
Novartis Investigative Site Charleston South Carolina 29406
Novartis Investigative Site Greer South Carolina 29650
Novartis Investigative Site Mt. Pleasant South Carolina 29464
Novartis Investigative Site Old Point Station South Carolina 29707
Novartis Investigative Site Spartanburg South Carolina 29303
Novartis Investigative Site Spartanburg South Carolina 29307
Novartis Investigative Site Knoxville Tennessee 37922
Novartis Investigative Site Nashville Tennessee 37205
Novartis Investigative Site Nashville Tennessee 37212
Novartis Investigative Site Brownwood Texas 76801
Novartis Investigative Site Dallas Texas 75214
Novartis Investigative Site Dallas Texas 75390
Novartis Investigative Site Houston Texas 77005
Novartis Investigative Site Houston Texas 77025
Novartis Investigative Site Kingwood Texas 77339
Novartis Investigative Site Mansfield Texas 76063
Novartis Investigative Site San Antonio Texas 78229
Novartis Investigative Site Stafford Texas 77477
Novartis Investigative Site Sugar Land Texas 77479
Novartis Investigative Site Provo Utah 84604
Novartis Investigative Site Salt Lake City Utah 84103
Novartis Investigative Site Salt Lake City Utah 84132
Novartis Investigative Site Alexandria Virginia 22310
Novartis Investigative Site Arlington Virginia 22205
Novartis Investigative Site Charlottesville Virginia 22911
Novartis Investigative Site McLean Virginia 22101
Novartis Investigative Site Newport News Virginia 23601
Novartis Investigative Site Norfolk Virginia 23507
Novartis Investigative Site Richmond Virginia 23228
Novartis Investigative Site Richmond Virginia 23924
Novartis Investigative Site Vienna Virginia 22182
Novartis Investigative Site Winchester Virginia 22601
Novartis Investigative Site Richland Washington 99352
Novartis Investigative Site Spokane Washington 99208
Novartis Investigative Site Tacoma Washington 98405
Novartis Investigative Site Wenatchee Washington 98801
Novartis Investigative Site Beckley West Virginia 25801
Novartis Investigative Site Huntington West Virginia 25701
Novartis Investigative Site Green Bay Wisconsin 54311
Novartis Investigative Site Milwaukee Wisconsin 53211
Novartis Investigative Site Monroe Wisconsin 53566
Novartis Investigative Site Neenah Wisconsin 54956
Novartis Investigative Site Wisconsin Rapids Wisconsin 54495
Novartis Investigative Site Casper Wyoming 82601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01442194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2022 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01442194 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →